Status:

TERMINATED

Physical Therapy for Systemic Lupus Erythematosus (SLE)

Lead Sponsor:

University of Chicago

Conditions:

Lupus Erythematosus, Systemic

SLE

Eligibility:

All Genders

16+ years

Phase:

NA

Brief Summary

The purpose of this study is to see if there is an improvement in patient's quality of life, pain, and fatigue after undergoing a supervised exercise program. If improvement is found, this will help g...

Detailed Description

After patients have been selected and consented for this study, they will fill out a series of questionnaires. These surveys are used to stratify the patient's disease activity, assess perception of d...

Eligibility Criteria

Inclusion

  • Diagnosis of SLE by ACR criteria; Age 16+ -

Exclusion

  • patients with an active lupus flare, or patients with physical limitations impairing their ability to participate in physical therapy. Other groups that will be excluded are those with limiting pulmonary disease and coronary artery disease. Patients with mechanical or structural abnormalities that would prohibit exercise (i.e. avascular necrosis of a weight-bearing joint) will also be excluded. Finally, patients already participating in a regular exercise program (\>1 day per week), or those with other conditions (based on the physicians discretion) which prohibit participating in physical therapy will not qualify for this study.

Key Trial Info

Start Date :

March 1 2003

Trial Type :

INTERVENTIONAL

End Date :

March 1 2007

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT00152555

Start Date

March 1 2003

End Date

March 1 2007

Last Update

June 12 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Chicago

Chicago, Illinois, United States, 60637